Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paroxetine 40mg tablets
0403030P0AAALAL
|
Paroxetine hydrochloride | Paroxetine hydrochloride | Central Nervous System | 15,303 |
|
Difflam Oral Rinse 0.15% solution
1203010E0BBAAAA
|
Difflam (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 15,269 |
|
Sodium valproate 100mg tablets
0408010W0AAABAB
|
Sodium valproate | Sodium valproate | Central Nervous System | 15,267 |
|
AproDerm ointment
21220000286
|
AproDerm ointment | Emollients | Appliances | 15,262 |
|
Dorzolamide 20mg/ml eye drops preservative free
1106000P0AAACAC
|
Dorzolamide | Dorzolamide | Eye | 15,211 |
|
Isopropyl myristate 15% / Liquid paraffin 15% gel
130201000AACACA
|
Generic compound emollients | Other emollient preparations | Skin | 15,196 |
|
Diethylamine salicylate 10% cream
1003020I0AAAAAA
|
Diethylamine salicylate | Diethylamine salicylate | Musculoskeletal and Joint Diseases | 15,190 |
|
NovoPen 6 hypodermic insulin inj pen reusable for 3ml cartridge 1 unit dial up/range 1-60 unit blue
21012600159
|
NovoPen 6 hypodermic insulin inj pen reusable for 3ml cartridge 1 unit dial up/range 1-60 unit blue | Other Appliances | Appliances | 15,170 |
|
Glimepiride 3mg tablets
0601021A0AAACAC
|
Glimepiride | Glimepiride | Endocrine System | 15,132 |
|
Buprenorphine 2mg sublingual tablets sugar free
0410030A0AAADAD
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 15,126 |
|
Colecalciferol 3,200unit capsules
0906040G0AADFDF
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 15,126 |
|
Fentanyl 25micrograms/hour transdermal patches
0407020A0AAAEAE
|
Fentanyl | Fentanyl | Central Nervous System | 15,120 |
|
Ciprofloxacin 250mg tablets
0501120L0AAAAAA
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | 15,093 |
|
Pentasa 2g modified-release granules sachets
0105010B0BCAFAT
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 15,053 |
|
Indometacin 50mg capsules
1001010K0AAABAB
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 15,034 |
|
Carbocisteine 750mg/10ml soln 10ml sachets sugar free
0307000J0AAAGAG
|
Carbocisteine | Carbocisteine | Respiratory System | 14,988 |
|
Eurax 10% cream
1303000I0BBABAA
|
Eurax (Topical Local Antipruritic) | Crotamiton | Skin | 14,986 |
|
Gentamicin 0.3% / Hydrocortisone acetate 1% ear drops
1201010G0AAACAC
|
Hydrocortisone acetate (Ear) | Hydrocortisone acetate | Ear, Nose and Oropharynx | 14,985 |
|
Mebendazole 100mg/5ml oral suspension
0505010D0AAAAAA
|
Mebendazole | Mebendazole | Infections | 14,977 |
|
Colecalciferol 50,000unit capsules
0906040G0AAEQEQ
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 14,975 |
|
Fenofibrate micronised 67mg capsules
0212000P0AAACAC
|
Fenofibrate | Fenofibrate | Cardiovascular System | 14,971 |
|
Lisdexamfetamine 70mg capsules
0404000U0AAAFAF
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 14,966 |
|
Evolve Carmellose 0.5% eye drops preservative free
21300000174
|
Evolve Carmellose 0.5% eye drops preservative free | Eye Products | Appliances | 14,949 |
|
GlucoRx FinePoint hypod insulin needles for pre-filled / reusable pen injectors screw on 8mm/31gauge
21010900805
|
GlucoRx FinePoint hypod insulin needles for pre-filled / reusable pen injectors screw on 8mm/31gauge | Other Appliances | Appliances | 14,917 |
|
Appeel No Sting medical adhesive remover aerosol
23150901504
|
Appeel No Sting medical adhesive remover aerosol | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 14,893 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.